The tumor microenvironment of cervical cancers has been well-studied, with some studies demonstrating the presence of tumor-infiltrating lymphocytes (TILs), and particularly CD8+ T-cells, to be strongly associated with improved clinical outcome and prognosis [28, 29]. The gene discussed is CD8A; the disease is cervical carcinoma.